- Exchange: NASDAQ GS
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Snapshot for Illumina Inc (ILMN)
| Open: | 43.3900 | Day's Range: | 43.3600 - 44.0700 | Volume: | 1,515,124 | Bid: | 43.8400 |
|---|---|---|---|---|---|---|---|
| Previous Close: | 43.4600 | 52wk Range: | 25.5700 - 79.4000 | 1-Yr Rtn: | -39.22% | Ask: | 43.8500 |
Key Statistics for ILMN
| Current P/E Ratio (ttm) | 40.9720 |
|---|---|
| Estimated P/E (12/2012) | 28.9564 |
| Earnings Per Share (USD) (ttm) | 1.0700 |
| Est. EPS (USD) (12/2012) | 1.5140 |
| Est. PEG Ratio | 1.5640 |
| Market Cap (M USD) | 5,411.96 |
| Shares Outstanding (M) | 123.45 |
| Enterprise Value (M USD) (ttm) | 4,961.57 |
| Enterprise Value/EBITDA (ttm) | 16.44 |
| Price/Book (mrq) | 4.6648 |
| Price/Sale (ttm) | 5.1341 |
| Dividend Indicated Gross Yield | 0.0000 |
| Next Earnings Announcement | 07/26/2012 |
More ILMN Key Statistics
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Financials for ILMN
- Operating
- Investing
- Financing (M/USD)
Company Profile & Key Executives for ILMN
Illumina, Inc. develops, manufactures and markets integrated systems for the large scale analysis of genetic variation and biological function. The Company provides a comprehensive line of products and services that currently serve the sequencing, genotyping and gene expression markets for genomic research centers, pharmaceutical companies, academic institutions and biotechnology companies.
| William H Rastetter "Bill"Chairman | Jay T FlatleyPresident/CEO |
| Marc StapleySenior VP/CFO | Mostafa RonaghiSenior VP/CTO |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Links
Top Forex Trading Resources
Advertisement
Advertisement
Advertisements
Rate this Page